Regulatory T - cell therapy represents a promising new frontier in
the immunotherapy of autoimmune disorders, especially for patients who have been refractory to available treatments.
Not exact matches
It's hoped this latest insight will lead to the widespread use
of antigen - specific
immunotherapy as a treatment for many
autoimmune disorders, including multiple sclerosis (MS), type 1 diabetes, Graves» disease and systemic lupus erythematosus (SLE).
In anti-NMDAR encephalitis and other
autoimmune disorders of the brain, the earlier
immunotherapy begins, the more complete the recovery.